<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Colin M.</namePart>
      <namePart type="family">Young</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-8225-3567</nameIdentifier>
      <displayForm>Young, Colin M.</displayForm>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Mark</namePart>
      <namePart type="family">Trusheim</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-6318-9037</nameIdentifier>
      <displayForm>Trusheim, Mark</displayForm>
      <affiliation>NEWDIGS Initiative, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Casey</namePart>
      <namePart type="family">Quinn</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-4329-7882</nameIdentifier>
      <displayForm>Quinn, Casey</displayForm>
      <affiliation>NEWDIGS Initiative, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA, USA</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-01-25</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>The recent marketing approval of several durable gene and cell therapies (2017-2020), together with observations that 7,000 monogenic indications and many cancers were potential targets, led to concern about the potential economic impact of such therapies on the US healthcare system. Using a Markov chain Monte Carlo simulation model, driven stochastically by our estimates of the time in phase of clinical trials and each clinical trial phase probability of success, we forecast the pattern of future US regulatory approvals for such therapies currently undergoing clinical trials. Using parameters of those trials, such as inclusion and exclusion criteria, and other epidemiological data we estimate potential treatable patient populations and use these together with pricing estimates to forecast a range for the potential future list price product revenues associated with these therapies. </abstract>
   <note type="admin">Pre-press version</note>
   <subject>
      <topic>Markov chain Monte Carlo</topic>
   </subject>
   <subject>
      <topic>Clinical trials</topic>
   </subject>
   <subject>
      <topic>Time in phase</topic>
   </subject>
   <subject>
      <topic>Success probability</topic>
   </subject>
   <subject>
      <topic>Durable cell and gene therapies</topic>
   </subject>
   <subject>
      <topic>Incidence and prevalence</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Data in Brief</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier Inc.</publisher>
      </originInfo>
      <identifier type="issn">2352-3409</identifier>
      <part>
         <text type="year">2022</text>
         <text type="month">01</text>
         <text type="day">25</text>
         <extent unit="pages">
            <start>107891</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.dib.2022.107891</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.dib.2022.107891</url>
   </location>
   <identifier type="pii">S2352-3409(22)00103-2</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY-NC-ND 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2022-01-27"/>
         <licence_ref>http://creativecommons.org/licenses/by-nc-nd/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2352-3409/aip/S2352340922001032/S2352340922001032.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
